Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar 29;14(3):441-447.
doi: 10.4103/tjo.TJO-D-22-00167. eCollection 2024 Jul-Sep.

Orbital metastasis of myxofibrosarcoma

Affiliations
Case Reports

Orbital metastasis of myxofibrosarcoma

Marissa K Shoji et al. Taiwan J Ophthalmol. .

Abstract

Myxofibrosarcoma (MFS), a common sarcoma in adults, typically affects the extremities. Primary orbital involvement is uncommon, and orbital metastasis is exceedingly rare. We describe a case of orbital MFS due to metastasis and provide an updated literature review. A 56-year-old woman presented with 2 months of progressive right eye proptosis. Relevant history included left palmar MFS excised 2 years prior. Examination demonstrated proptosis and restriction in abduction of her right eye without optic nerve compromise. Imaging revealed a well-circumscribed right orbital mass. Initial biopsy showed glandular tissue with chronic inflammation without an evidence of malignancy. She subsequently developed worsening proptosis, complete ophthalmoplegia, and a new afferent pupillary defect. Repeat orbital excisional biopsy with deeper dissection demonstrated high-grade MFS consistent with metastasis. She underwent chemoradiation with resolution of her lesion. Literature review identified 12 previously reported cases of MFS, only two of which involved metastasis to the orbit and were associated with worse prognosis. This report highlights a rare case of orbital metastasis of MFS with high-grade features confirmed on histopathology and provides an updated literature review. Prompt diagnosis and complete removal of MFS located both systemically and in the orbit are essential due to the metastatic potential.

Keywords: Metastasis; myxofibrosarcoma; orbit; orbital tumor; tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interests of this paper.

Figures

Figure 1
Figure 1
External photographs of the patient demonstrating hypoglobus and medial displacement of the right eye with restriction in upgaze and abduction
Figure 2
Figure 2
T1-weighted fat-suppressed magnetic resonance imaging. Coronal (a) and axial (b) images demonstrate an enhancing mass along the lateral aspect of the right orbit as indicated by white arrows
Figure 3
Figure 3
(a) Histopathology of the orbital mass demonstrates a hypercellular neoplasm composed of cytologically malignant pleomorphic spindle cells and epithelioid cells enmeshed in a myxoid stroma that contains arching, interconnecting blood vessels (H and E, original magnification ×100). (b) Mitotic figures are present (arrows), consistent with cytologic malignancy (H and E, original magnification ×400). The findings are morphologically similar to the primary high-grade lesion originating in the soft tissue of the left palm (c) H and E, original magnification ×40, (d) H and E, original magnification ×600, mitotic figures indicated by black arrows
Figure 4
Figure 4
Clinical and radiographic findings at follow-up. (a) External examination of the patient at 15-month follow-up after receiving treatment with orbital radiation and systemic chemotherapy demonstrate clinical resolution of her proptosis. T1-weighted fat-suppressed magnetic resonance imaging with coronal (b) and axial (c) images following treatment demonstrate postsurgical changes without evidence of orbital lesion recurrence

References

    1. Angervall L, Kindblom LG, Merck C. Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A. 1977;85A:127–40. - PubMed
    1. Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20:391–405. - PubMed
    1. Willems SM, Debiec-Rychter M, Szuhai K, Hogendoorn PC, Sciot R. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol. 2006;19:407–16. - PubMed
    1. Sanfilippo R, Miceli R, Grosso F, Fiore M, Puma E, Pennacchioli E, et al. Myxofibrosarcoma: Prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2011;18:720–5. - PubMed
    1. Lin CN, Chou SC, Li CF, Tsai KB, Chen WC, Hsiung CY, et al. Prognostic factors of myxofibrosarcomas: Implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol. 2006;93:294–303. - PubMed

Publication types

LinkOut - more resources